Garry Erwin Fined For Phenylbutazone Positive In New South Wales

Greyhound yesterday inquired into analyst’s reports that the urine sample taken from Altario after that greyhound won Race 3 at the meeting on 30 July this year, had been analysed and confirmed to contain the , and its metabolites, oxyphenbutazone and gamma hydroxyphenylbutazone.

Evidence was taken from trainer Mr. Garry Erwin, fellow trainer Mr. Ross Penney and Australian Racing Forensic Laboratory Science Manager Dr Adam Cawley, with written evidence tendered from the Australian Racing Forensic Laboratory, Racing Analytical Services and from Mr. Erwin.

Mr. Erwin subsequently pleaded guilty to a charge under GAR 83 (2) (a) in that he presented Altario for the race in question other than free of prohibited substances in that the urine sample taken from the greyhound after the race was found to contain the prohibited substances phenylbutazone, oxyphenbutazone and gamma hydroxyphenylbutazone.

Mr. Erwin was subsequently fined $1500. In considering penalty Stewards took into account Mr. Erwin’s previously unblemished record in relation to the prohibited substance in almost twenty years of licencing, his personal standing within the industry where he involves himself at an official level with race clubs, the nature of the substance involved and other penalties in relation to such reports, and that there had been no support outside of normal parameters for the greyhound. Stewards also considered Mr. Erwin’s plea of guilty to the charge, his personal circumstances, and the small number of greyhounds in his care, as well as a number of personal references supplied.

Altario was disqualified from the race in question and the placings amended accordingly.

0 0 votes
Article Rating

More Greyhounds News

Notify of
Inline Feedbacks
View all comments